How India's slow vaccination hurts poor countries https://ift.tt/eA8V8J

Of the 2 billion doses that Covax needs to supply to low income countries this year, 1.1 billion doses were to be supplied by the Pune-based Serum Institute of India (SII), comprising Covishield and Novavax. However, the Centre had imposed an unofficial ban on export of all vaccines in March as India suffered from twin blows of low vaccine stocks for its own population and a devastating second wave of Covid-19.

from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/3C0yHfp